全文获取类型
收费全文 | 537篇 |
免费 | 46篇 |
国内免费 | 1篇 |
出版年
2018年 | 8篇 |
2017年 | 11篇 |
2016年 | 14篇 |
2015年 | 11篇 |
2014年 | 17篇 |
2013年 | 12篇 |
2012年 | 22篇 |
2011年 | 26篇 |
2010年 | 16篇 |
2009年 | 15篇 |
2008年 | 20篇 |
2007年 | 17篇 |
2006年 | 7篇 |
2005年 | 12篇 |
2004年 | 9篇 |
2003年 | 17篇 |
2002年 | 9篇 |
2001年 | 12篇 |
2000年 | 11篇 |
1999年 | 9篇 |
1998年 | 11篇 |
1997年 | 16篇 |
1996年 | 5篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 13篇 |
1992年 | 8篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 7篇 |
1988年 | 14篇 |
1987年 | 8篇 |
1986年 | 10篇 |
1985年 | 5篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 7篇 |
1979年 | 8篇 |
1977年 | 7篇 |
1975年 | 12篇 |
1974年 | 10篇 |
1973年 | 12篇 |
1972年 | 9篇 |
1971年 | 7篇 |
1969年 | 7篇 |
1967年 | 7篇 |
1965年 | 5篇 |
1953年 | 5篇 |
排序方式: 共有584条查询结果,搜索用时 93 毫秒
581.
The uptake of C14-labeled proteins (lysozyme, hemoglobin, lactoglobulin, and ovalbumin) from solution by tomato plants with sterile roots was studied. It was found that C14-compounds (proteins and/or protein-degradation products) were translocated to the foliage if the roots had undergone minor mechanical injury or if the plants were subjected to temporary wilting, i.e., physiological damage. C14-lysozyme was not transported to foliar tissue in healthy plants; C14-hemoglobin showed radioactivity in leaves of both healthy and injured plants, but there was evidence of a breakdown of the molecule; C14-ovalbumin gave a faint labeling of foliar tissues of some plants in which wilting or mechanical damage was below the threshold of detection. It is concluded, however, that translocation of proteins from roots in nutrient solution to tomato leaves does not occur in significant amounts in healthy plants in spite of the large uptake of proteins by root cortex, as found in earlier studies. 相似文献
582.
R. M. MacKie D. Hole J. A. Hunter R. Rankin A. Evans K. McLaren M. Fallowfield A. Hutcheon A. Morris 《BMJ (Clinical research ed.)》1997,315(7116):1117-1121
OBJECTIVE: To determine the changing incidence of and mortality from cutaneous malignant melanoma in Scotland from 1979 to 1994. DESIGN: Detailed registration of clinical and pathological features, surgical and other treatment, and follow up of all cases of cutaneous malignant melanoma diagnosed from 1979 to 1994 and registered with specialist database for Scotland. SETTING: Scotland. SUBJECTS: 6288 patients with invasive primary cutaneous malignant melanoma diagnosed between 1 January 1979 and 31 December 1994. RESULTS: The annual age standardised incidence of cutaneous malignant melanoma rose significantly from 3.5 to 7.8 per 100,000 per year in men and from 6.8 to 12.3 per 100,000 per year in women (P < 0.001 for both). World standardised rates increased from 2.7 to 6.0 per 100,000 per year in men and 4.6 to 8.50 per 100,000 in women. The incidence of melanoma continued to increase significantly in men of all ages during the study, but the rate stabilised in women after 1986. Mortality from cutaneous malignant melanoma was 1.3 per million per annum in men in 1979, rising to 2.3 per million per annum in 1994 (P < 0.01); it was 2.4 per million per annum in women in 1979, falling to 1.9 per million per annum in 1994 (P = 0.09). The underlying mortality trends showed a continuing rise for men but a downward trend for women that was not significant (P = 0.09). In men, melanoma free survival was 69% at 5 years and 61% at 10 years; in women the corresponding rates were 82% and 75%. Younger patients had higher survival rates, which were not entirely explained by thinner tumours. Over the 15 year period, survival rates improved by 12% overall, only partly owing to thinner tumours. CONCLUSIONS: In Scotland the incidence of melanoma in women has stabilised, while mortality associated with melanoma in women shows a downward trend. 相似文献
583.
Annemijn Vis Jan CAM Lammers Roel de Vroege Martijn MJ van Nieuwburg Marlijn S Jansen Joyce MJ Visser Bart Meuris Paul F Gründeman Jolanda Kluin 《Comparative medicine》2021,71(3):235
Sheep are a commonly used and validated model for cardiovascular research and, more specifically, for heart valve research. Implanting a heart valve on the arrested heart in sheep is complex and is often complicated by difficulties in restarting the heart, causing significant on-table mortality. Therefore, optimal cardioprotective management during heart valve implantation in sheep is essential. However, little is known about successful cardioprotective management techniques in sheep. This article reports our experience in the cardioprotective management of 20 female sheep that underwent surgical aortic valve replacement with a stented tissue-engineered heart valve prosthesis. During this series of experiments, we modified our cardioprotection protocol to improve survival. We emphasize the importance of total body hypothermia and external cooling of the heart. Furthermore, we recommend repeated cardioplegia administration at 20 min intervals during surgery, with the final dosage of cardioplegia given immediately before the de-clamping of the aorta. To reduce the number of defibrillator shocks during a state of ventricular fibrillation (VF), we have learned to restart the heart by reclamping the aorta, administering cardioplegia until cardiac arrest, and de-clamping the aorta thereafter. Despite these encouraging results, more research is needed to finalize a protocol for this procedure.Sheep are a commonly used and well-validated model for cardiovascular research, particularly for heart valve research, as blood pressure, heart rate, cardiac output, and intracardiac pressures are similar between sheep and humans. Sheep are particularly useful for heart valve research because observable changes in implanted heart valve bioprostheses that would take several years to develop in humans are apparent after only a few months in sheep.3,11 This feature allows the ovine model to provide relevant and important information about heart valve prostheses in a relatively short time span. The first preclinical step in developing novel heart valves is to test the valve in the pulmonary position in sheep. This surgical technique is relatively easy, as the procedure can be performed on a beating heart in a low-pressure circulation. However, aortic valve surgery is the most frequently performed valvular surgical intervention in human patients.12 Thus, an important next step is to prove the clinical applicability of a new valve by testing the valve in-vivo in the aortic position in an animal model. In contrast to pulmonary valve replacement, aortic valve replacement must be performed on an arrested heart, which makes the surgical procedure significantly more complex. The sheep is a difficult model for aortic valve replacements due to its narrow annulus, short distance between the annulus and coronary ostia, a short ascending aorta, and difficulty in de-airing of the heart prior to suturing the aortotomy.19 Consequently, high on-table mortality rates, ranging from 9% to 33%, have been reported.1,18,21,24 Furthermore, the incidence of mortality during the first 30 d after surgery, directly related to the surgical procedure, is often high, ranging from 17% to 50%.1,2,16,18,21 Therefore, optimizing cardioprotective strategies during surgery would improve postoperative survival. However, little is known about protective strategies in sheep. In the current series of experiments, we implanted stented, tissue engineered, aortic heart valve prostheses in 20 adult domestic sheep and developed cardioprotective techniques to increase survival rates. In this observational study, we share our experience and insights regarding cardioprotective management to potentially improve the outcome of future surgeries that require an arrested heart in sheep. 相似文献
584.
Effect of praziquantel on the migration and survival of developmental stages of Schistosoma mansoni in mice 总被引:1,自引:0,他引:1
Compressed organ autoradiography has been used to determine whether the anthelmintic drug praziquantel (Pzq) modifies the migration of isotopically labelled Schistosoma mansoni during the first 16 days of infection in CBA/Ca mice. The mice were treated with 500 mg kg-1 body weight of the drug on day 1 or day 6. Treatment caused a marked delay in parasite migration from the skin when the drug was administered intradermally at the site of infection on day 1; migration from the lungs was also delayed after such treatment. Pzq injected either intradermally on day 1 or intramuscularly on day 6 effectively reduced the number of parasites that finally arrived in the lungs and the livers by 41 and 47%, respectively. Intramuscular administration of the drug on day 1 had a negligible effect. Worm recoveries assessed on day 38 by perfusion of the hepatic portal system were greatly reduced when Pzq was administered on day 14. The worms proved less susceptible when the drug was administered on day 21 and were completely resistant following drug delivery on day 28. The influence of drug preparation and route of delivery on parasite migration and survival are discussed. 相似文献